NSM Open: Open Nipple Sparing Mastectomy (NSM)

Sponsor
Intuitive Surgical (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04447339
Collaborator
(none)
75
5
22.3
15
0.7

Study Details

Study Description

Brief Summary

This is retrospective, multicenter chart review is to evaluate the complication rates of prophylactic open NSM procedures through 42 days postoperatively

Condition or Disease Intervention/Treatment Phase
  • Procedure: Nipple Sparing Mastectomy

Detailed Description

This is retrospective, multicenter chart review is to evaluate the complication rates of prophylactic open NSM procedures through 42 days postoperatively

Study Design

Study Type:
Observational
Anticipated Enrollment :
75 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
A Retrospective, Multicenter Study of Open Nipple Sparing Mastectomy (NSM)
Actual Study Start Date :
Sep 21, 2020
Anticipated Primary Completion Date :
May 30, 2022
Anticipated Study Completion Date :
Jul 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Open

Prophylactic NSM cases by Open approach

Procedure: Nipple Sparing Mastectomy
Prophylactic open NSM procedures

Outcome Measures

Primary Outcome Measures

  1. Safety Endpoint: complication rate [IntraOperative period through 42 days postoperatively]

    To assess the number of open prophylactic nipple sparing mastectomy complications compared to the number of procedures

  2. Effectiveness [IntraOperative period through 42 days postoperatively]

    Ability to completely excise memory gland tissue and preserve Nipple Areola Complex

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:

All female patients that have undergone open prophylactic NSM cases performed between January 1, 2018 through 42 days prior to IRB approval

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 NorthShore University Health System Evanston Illinois United States 60201
2 Mayo Clinic Hosp - Methodist Campus - MN Rochester Minnesota United States 55905
3 Northwell Health Queens New York United States 11040
4 Pennsylvania Hospital Philadelphia Pennsylvania United States 19107
5 Univ. of Texas MD Anderson Cancer Center Houston Texas United States 77030

Sponsors and Collaborators

  • Intuitive Surgical

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Intuitive Surgical
ClinicalTrials.gov Identifier:
NCT04447339
Other Study ID Numbers:
  • ISI-RoNSM-01
First Posted:
Jun 25, 2020
Last Update Posted:
Jan 11, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 11, 2022